ATE374769T1 - Beta-lactam-verbindungen, verfahren zu deren herstellung und serumcholesterinsenkende mittel, die diese verbindungen enthalten - Google Patents
Beta-lactam-verbindungen, verfahren zu deren herstellung und serumcholesterinsenkende mittel, die diese verbindungen enthaltenInfo
- Publication number
- ATE374769T1 ATE374769T1 AT02703861T AT02703861T ATE374769T1 AT E374769 T1 ATE374769 T1 AT E374769T1 AT 02703861 T AT02703861 T AT 02703861T AT 02703861 T AT02703861 T AT 02703861T AT E374769 T1 ATE374769 T1 AT E374769T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- carbon atoms
- compounds
- chain
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001048202 | 2001-02-23 | ||
JP2001128031 | 2001-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE374769T1 true ATE374769T1 (de) | 2007-10-15 |
Family
ID=26609978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02703861T ATE374769T1 (de) | 2001-02-23 | 2002-02-20 | Beta-lactam-verbindungen, verfahren zu deren herstellung und serumcholesterinsenkende mittel, die diese verbindungen enthalten |
Country Status (18)
Country | Link |
---|---|
US (1) | US7045515B2 (de) |
EP (1) | EP1362855B1 (de) |
JP (1) | JP4229701B2 (de) |
KR (1) | KR100721639B1 (de) |
CN (1) | CN1273467C (de) |
AT (1) | ATE374769T1 (de) |
AU (1) | AU2002237522B2 (de) |
BR (1) | BRPI0206193B1 (de) |
CA (1) | CA2438961C (de) |
DE (1) | DE60222742T2 (de) |
DK (1) | DK1362855T3 (de) |
ES (1) | ES2294101T3 (de) |
HK (1) | HK1060357A1 (de) |
MX (1) | MXPA03005073A (de) |
PT (1) | PT1362855E (de) |
RU (1) | RU2301799C2 (de) |
TW (1) | TWI291957B (de) |
WO (1) | WO2002066464A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0208384B1 (pt) | 2001-03-28 | 2016-05-31 | Merck Sharp & Dohme | síntese enantiosseletiva de compostos intermediários de azetidinona |
GB0215579D0 (en) * | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
JP2005015434A (ja) * | 2003-06-27 | 2005-01-20 | Kotobuki Seiyaku Kk | 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤 |
EP1682117A1 (de) * | 2003-10-30 | 2006-07-26 | Merck & Co., Inc. | 2-azetidinone als anti-hypercholesterinämische mittel |
EP1918000A2 (de) | 2003-11-05 | 2008-05-07 | Schering Corporation | Verbindungen aus lipidverändernden Wirkstoffen und substituierten Azetidinonen und Behandlungen für Gefäßzustände |
EP1832576A1 (de) * | 2003-11-10 | 2007-09-12 | Microbia Inc. | 4-Biarylyl-1-phenolyzetidin-2-ones |
WO2005047248A1 (en) * | 2003-11-10 | 2005-05-26 | Microbia, Inc. | 4-biarylyl-1-phenylazetidin-2-ones |
CN100471835C (zh) | 2003-12-23 | 2009-03-25 | 默克公司 | 抗高胆固醇血症化合物 |
SA04250427A (ar) | 2003-12-23 | 2005-12-03 | استرازينيكا ايه بي | مشتقات ثاني فينيل أزيتيدون |
MXPA06013456A (es) | 2004-05-21 | 2007-03-01 | Sanofi Aventis Deutschland | Metodo para producir derivados de 1,4-difenilazetidinona. |
EP1807070A1 (de) * | 2004-09-29 | 2007-07-18 | Schering Corporation | Kombinationen aus substituierten azetidinonen und cb1-antagonisten |
SG163577A1 (en) | 2004-12-03 | 2010-08-30 | Schering Corp | Substituted piperazines as cb1 antagonists |
TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
CA2608075A1 (en) * | 2005-05-11 | 2006-11-16 | Microbia, Inc. | Processes for production of phenolic 4-biphenylylazetidin-2-ones |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
EP1896135A2 (de) * | 2005-05-25 | 2008-03-12 | Microbia, Inc. | Verfahren zur herstellung von 4-(biphenylyl)azetidin-2-on-phosphonsäuren |
CA2611142A1 (en) * | 2005-06-15 | 2006-12-28 | Merck & Co., Inc. | Anti-hypercholesterolemic compounds |
MX2008000115A (es) | 2005-06-20 | 2008-03-18 | Schering Corp | Derivados de piperidina utiles como antagonistas de histamina h3. |
UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
AR057072A1 (es) | 2005-06-22 | 2007-11-14 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
BRPI0617207A2 (pt) | 2005-09-29 | 2011-07-19 | Sanofi Aventis | derivados de fenil-1,2,4-oxadiazolona, processos para sua preparação e seu uso como produtos farmacêuticos |
TW200806623A (en) * | 2005-10-05 | 2008-02-01 | Merck & Co Inc | Anti-hypercholesterolemic compounds |
CA2637565A1 (en) * | 2006-01-18 | 2007-07-26 | Schering Corporation | Cannibinoid receptor modulators |
JP4880348B2 (ja) * | 2006-04-25 | 2012-02-22 | 壽製薬株式会社 | アズレン誘導体及びそれを有効成分とする血清コレステロール低下剤 |
TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
EP2061792A2 (de) | 2006-09-15 | 2009-05-27 | Schering Corporation | Azetidinon-derivate und verwendungsverfahren dafür |
JP2010503672A (ja) * | 2006-09-15 | 2010-02-04 | シェーリング コーポレイション | 脂質代謝障害、疼痛、糖尿病、および他の障害を治療するためのスピロ環アゼチジノン誘導体 |
MX2009002922A (es) | 2006-09-15 | 2009-04-01 | Schering Corp | Derivados de azetidina y azetidona utiles en el tratamiento del dolor y de trastornos del metabolismo lipidico. |
US7638526B2 (en) | 2006-09-15 | 2009-12-29 | Schering Corporation | Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
EP2124549A4 (de) * | 2006-12-20 | 2010-01-20 | Merck & Co Inc | Antihypercholesterinämische verbindungen |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2008130616A2 (en) * | 2007-04-19 | 2008-10-30 | Schering Corporation | Diaryl morpholines as cb1 modulators |
JP2010531874A (ja) * | 2007-06-28 | 2010-09-30 | インターベット インターナショナル ベー. フェー. | Cb1アンタゴニストとしての置換ピペラジン |
KR20100051625A (ko) * | 2007-06-28 | 2010-05-17 | 인터벳 인터내셔널 비.브이. | Cb1 길항제로서의 치환된 피페라진 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007063671A1 (de) | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
EP2310372B1 (de) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclische Verbindungen, Verfahren zu ihrer Herstellung, Arzneimitteln mit diesen Verbindungen und ihre Verwendung |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
EP2379562A1 (de) | 2008-12-16 | 2011-10-26 | Schering Corporation | Bicyclische pyranonderivate als agonisten am nicotinsäurerezeptor |
US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
CA2754384A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
US8785608B2 (en) | 2009-08-26 | 2014-07-22 | Sanofi | Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
CN104860980B (zh) * | 2015-04-23 | 2018-06-19 | 上海弈柯莱生物医药科技有限公司 | 一种用于合成依折麦布的中间体及其制备方法和应用 |
US11504390B2 (en) | 2019-03-20 | 2022-11-22 | Regeneron Pharmaceuticals, Inc. | Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors |
US11331332B2 (en) | 2019-03-20 | 2022-05-17 | Regeneron Pharmaceuticals, Inc. | Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5857360A (ja) * | 1981-10-01 | 1983-04-05 | Ajinomoto Co Inc | アゼチジノン誘導体 |
SK7994A3 (en) | 1991-07-23 | 1994-07-06 | Schering Corp | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes of their preparation |
US5412092A (en) * | 1993-04-23 | 1995-05-02 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
BR9612998B1 (pt) * | 1995-10-31 | 2010-03-23 | 2-azetidinonas substituÍdas com aÇécar éteis como agentes hipocolesterolÊmicos, composiÇço farmacÊutica e kit contendo as mesmas. | |
WO1997016424A1 (en) * | 1995-11-02 | 1997-05-09 | Schering Corporation | Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinone |
AU2002231688A1 (en) * | 2000-12-21 | 2002-07-01 | Sanofi-Aventis Deutschland Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
-
2002
- 2002-02-08 TW TW091102310A patent/TWI291957B/zh not_active IP Right Cessation
- 2002-02-20 DE DE60222742T patent/DE60222742T2/de not_active Expired - Lifetime
- 2002-02-20 DK DK02703861T patent/DK1362855T3/da active
- 2002-02-20 EP EP02703861A patent/EP1362855B1/de not_active Expired - Lifetime
- 2002-02-20 RU RU2003128424/04A patent/RU2301799C2/ru not_active IP Right Cessation
- 2002-02-20 ES ES02703861T patent/ES2294101T3/es not_active Expired - Lifetime
- 2002-02-20 CA CA2438961A patent/CA2438961C/en not_active Expired - Fee Related
- 2002-02-20 MX MXPA03005073A patent/MXPA03005073A/es active IP Right Grant
- 2002-02-20 BR BRPI0206193A patent/BRPI0206193B1/pt not_active IP Right Cessation
- 2002-02-20 WO PCT/JP2002/001481 patent/WO2002066464A1/ja active IP Right Grant
- 2002-02-20 KR KR1020037010927A patent/KR100721639B1/ko not_active IP Right Cessation
- 2002-02-20 AU AU2002237522A patent/AU2002237522B2/en not_active Ceased
- 2002-02-20 CN CNB028052013A patent/CN1273467C/zh not_active Expired - Fee Related
- 2002-02-20 PT PT02703861T patent/PT1362855E/pt unknown
- 2002-02-20 US US10/450,171 patent/US7045515B2/en not_active Expired - Lifetime
- 2002-02-20 JP JP2002565979A patent/JP4229701B2/ja not_active Expired - Lifetime
- 2002-02-20 AT AT02703861T patent/ATE374769T1/de active
-
2004
- 2004-05-12 HK HK04103348A patent/HK1060357A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPWO2002066464A1 (ja) | 2004-06-17 |
DK1362855T3 (da) | 2008-01-28 |
CA2438961A1 (en) | 2002-08-29 |
DE60222742T2 (de) | 2008-07-17 |
AU2002237522B2 (en) | 2007-08-02 |
TWI291957B (en) | 2008-01-01 |
MXPA03005073A (es) | 2003-09-05 |
CA2438961C (en) | 2010-02-16 |
EP1362855B1 (de) | 2007-10-03 |
RU2003128424A (ru) | 2005-01-27 |
PT1362855E (pt) | 2007-12-04 |
CN1492865A (zh) | 2004-04-28 |
KR100721639B1 (ko) | 2007-05-23 |
WO2002066464A1 (en) | 2002-08-29 |
EP1362855A1 (de) | 2003-11-19 |
US20040063929A1 (en) | 2004-04-01 |
DE60222742D1 (de) | 2007-11-15 |
BR0206193A (pt) | 2004-02-03 |
RU2301799C2 (ru) | 2007-06-27 |
HK1060357A1 (en) | 2004-08-06 |
US7045515B2 (en) | 2006-05-16 |
CN1273467C (zh) | 2006-09-06 |
JP4229701B2 (ja) | 2009-02-25 |
ES2294101T3 (es) | 2008-04-01 |
EP1362855A4 (de) | 2005-02-23 |
BRPI0206193B1 (pt) | 2016-05-24 |
KR20030076690A (ko) | 2003-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE374769T1 (de) | Beta-lactam-verbindungen, verfahren zu deren herstellung und serumcholesterinsenkende mittel, die diese verbindungen enthalten | |
DE69518627D1 (de) | Pharmazeutisch wirksame verbindungen und liposome und verfahren zu deren herstellung | |
HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
ATE254612T1 (de) | Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen | |
ATE327230T1 (de) | Piperidinverbindungen und diese enthaltenden medikamente | |
ATE482968T1 (de) | Estra-1,3,5(10)-trien-3-sulfamat derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
KR940005534A (ko) | 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제 | |
EP1147772A4 (de) | Medizinische zusammensetzungen zur behandlung der vorhof-fibrillation | |
HUP9801671A2 (hu) | Új hexahidro-1,4-diazepin-származékok, sóik és ezeket tartalmazó gyógyszerkészítmények | |
ATE211137T1 (de) | Substituierte benzylthienylpiperazine, ihre anwendung als arzneimittel und verfahren für ihre herstellung | |
KR930003911A (ko) | 치환된 방향족 아미드 잔기를 갖는 아미노카르복실레이트 리간드 | |
UA66888C2 (uk) | 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів | |
DE69029861T2 (de) | N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
ATE160566T1 (de) | Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel | |
DE60116902D1 (de) | Neue desloratadinsalze, verfahren zu deren synthese und diese enthaltende pharmazeutische zusammensetzungen | |
DE60032460D1 (de) | Kryptatverbindungen und verfahren zur diagnose und therapie | |
DE69533214D1 (de) | 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme | |
MY136928A (en) | New isoquinoline compounds, a process for their preparation and pharmaceutical composition containing them | |
ATE281452T1 (de) | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
DE69500198D1 (de) | Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen | |
DE60116655D1 (de) | Carbamatderivate, verfahren zu deren herstellung und deren verwendung | |
AU547599B2 (en) | Tricyclic compounds | |
TH17047A (th) | อนุพันธ์ของ n-ซับสทิทิวเทด อะซาไบไซโคลเฮพเทน, การเตรียมและการใช้ประโยชน์ของสารเหล่านี้ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1362855 Country of ref document: EP |